Here you can find more information about Ryaltris® (olopatadine/mometasone furoate).
Please select one of the options below:
If neither of the two options apply to you, but you would like more information, please refer to the following:
Summary of Product Characteristics Patient Information Leaflet Public Assessment Report
By clicking this link, you are leaving the Ryaltris® website and entering a third party website. Glenmark Pharmaceuticals has no control over the content and management of third party websites and cannot be held responsible or liable for this. Please check that the content of the website you are about to visit is suitable for you, and that you are the intended audience. It is recommended that you carefully read the legal notices and privacy and cookie policies of third party websites before accessing them.
If you wish to continue, please click ‘Continue’, otherwise click ‘Stay on page.’